These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

286 related items for PubMed ID: 2844337

  • 21. Posttransfusion cytomegalovirus infections.
    Tegtmeier GE.
    Arch Pathol Lab Med; 1989 Mar; 113(3):236-45. PubMed ID: 2537614
    [Abstract] [Full Text] [Related]

  • 22. Prevention of CMV infection after BMT in high-risk patients using CMV hyperimmune globulin.
    Einsele H, Vallbracht A, Schmidt H, Friese M, Schüch K, Haen M, Dopfer R, Niethammer D, Waller HD, Ehninger G.
    Cancer Detect Prev; 1988 Mar; 12(1-6):637-41. PubMed ID: 2846173
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Cytomegalovirus antibody avidity in allogeneic bone marrow recipients: evidence for primary or secondary humoral responses depending on donor immune status.
    Lutz E, Ward KN, Szydlo R, Goldman JM.
    J Med Virol; 1996 May; 49(1):61-5. PubMed ID: 8732861
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. [Specific anti-cytomegalovirus immunoglobulins in the prevention of cytomegalovirus infections in bone marrow allografts].
    Huart JJ, Baume D, Jouet JP.
    Ann Med Interne (Paris); 1987 May; 138(5):372-4. PubMed ID: 2823667
    [Abstract] [Full Text] [Related]

  • 30. Use of leukocyte-depleted platelets and cytomegalovirus-seronegative red blood cells for prevention of primary cytomegalovirus infection after marrow transplant.
    Bowden RA, Slichter SJ, Sayers MH, Mori M, Cays MJ, Meyers JD.
    Blood; 1991 Jul 01; 78(1):246-50. PubMed ID: 1648976
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Bone marrow transplantation for chronic myeloid leukemia (CML) from unrelated and sibling donors: single center experience.
    Lamparelli T, Van Lint MT, Gualandi F, Occhini D, Barbanti M, Sacchi N, Ficai G, Ghinatti C, Ferrara GB, Delfino L, Pozzi S, Morabito A, Zikos P, Vitale V, Corvo R, Frassoni F, Bacigalupo A.
    Bone Marrow Transplant; 1997 Dec 01; 20(12):1057-62. PubMed ID: 9466278
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Bone marrow transplantation from a pediatric donor with a high frequency of cytomegalovirus-specific T-cells.
    Komatsu H, Kogawa K, Nonoyama S, Inui A, Sogo T, Fujisawa T, Klenerman P.
    J Med Virol; 2006 Dec 01; 78(12):1616-23. PubMed ID: 17063516
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Influence of cytomegalovirus seropositivity on outcome after T cell-depleted bone marrow transplantation: contrasting results between recipients of grafts from related and unrelated donors.
    Meijer E, Dekker AW, Rozenberg-Arska M, Weersink AJ, Verdonck LF.
    Clin Infect Dis; 2002 Sep 15; 35(6):703-12. PubMed ID: 12203168
    [Abstract] [Full Text] [Related]

  • 40. Ganciclovir prophylaxis for cytomegalovirus infection in pediatric allogeneic bone marrow transplant recipients.
    Canpolat C, Culbert S, Gardner M, Whimbey E, Tarrand J, Chan KW.
    Bone Marrow Transplant; 1996 Apr 15; 17(4):589-93. PubMed ID: 8722360
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 15.